About the Authors
- Kasmintan A. Schrader
-
Contributed equally to this work with: Kasmintan A. Schrader, Bella Gorbatcheva
Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Bella Gorbatcheva
-
Contributed equally to this work with: Kasmintan A. Schrader, Bella Gorbatcheva
Affiliation Novartis Institute for Biomedical Research, Cambridge, Massachusetts, United States of America
- Janine Senz
-
Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Alireza Heravi-Moussavi
-
Affiliation Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- Nataliya Melnyk
-
Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Clara Salamanca
-
Affiliation Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- Sarah Maines-Bandiera
-
Affiliation Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- Susanna L. Cooke
-
Affiliation Cancer Research, Cambridge Research Institute, Cambridge, United Kingdom
- Peter Leung
-
Affiliation Department of Obstetrics and Gynecology, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada
- James D. Brenton
-
Affiliation Cancer Research, Cambridge Research Institute, Cambridge, United Kingdom
- C. Blake Gilks
-
Affiliation Genetic Pathology and Evaluation Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada
- John Monahan
-
Affiliation Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- David G. Huntsman
-
* E-mail: dhuntsma@bccancer.bc.ca
Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Novartis Institute for Biomedical Research, Cambridge, Massachusetts, United States of America, Genetic Pathology and Evaluation Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada
Competing Interests
The British Columbia Cancer Agency is the holder of a provisional patent on the use of the FOXL2 mutation as a potential diagnostic and therapeutic target. Bella Gorbatcheva and John Monahan are both employees of the Novartis Institutes for BioMedical Research. These competing interests do not impact the sharing of data related to this publication.
Author Contributions
Conceived and designed the experiments: KAS BG JDB CBG JM DH. Performed the experiments: BG JS AHM NM CS SMB SLC JM. Analyzed the data: KAS BG JS AHM NM PL JDB CBG JM DH. Contributed reagents/materials/analysis tools: CS SMB SLC PL JDB CBG JM. Wrote the paper: KAS BG JDB JM DH.